Impact of using triclosan-antibacterial sutures on incidence of surgical site infection

American Journal of Surgery

Volumn 202, Issue 2, 2011, Pages 133-138

  Galal, Ibrahim ^a   El Hindawy, Khaled ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

Antimicrobial triclosan coated polyglactin 910 suture; Length of hospital stay; Surgical site infection

Indexed keywords

POLYGLACTIN; SUTURE MATERIAL; TRICLOSAN;

ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EGYPT; FEMALE; HEALTH CARE COST; HUMAN; INCIDENCE; INFECTION RISK; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SURGICAL INFECTION; SUTURE;

ADULT; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS, LOCAL; COATED MATERIALS, BIOCOMPATIBLE; DIOXANES; DOUBLE-BLIND METHOD; EGYPT; FEMALE; HOSPITAL COSTS; HOSPITALS, UNIVERSITY; HUMANS; INCIDENCE; LENGTH OF STAY; MALE; MIDDLE AGED; POLYESTERS; POLYGLACTIN 910; PROSPECTIVE STUDIES; RISK FACTORS; SURGICAL WOUND INFECTION; SUTURES; TRICLOSAN; WOUND HEALING;

EID: 79960976230     PISSN: 00029610     EISSN: 18791883     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2010.06.011     Document Type: Article

References (20)

1. Barie PS. Surgical site infections: epidemiology and prevention. Surg Infect Larchmt 2002;3(Suppl):9-21.
2. Leaper DJ, van Goor H, Reilly J, et al. Surgical site infection - a European perspective of incidence and economical burden. Int Wound J 2004;1:247-73.
3. Fry DE. The economic costs of surgical site infection. Surg Infect Larchmt 2002;3(Suppl):37-45.
4. Berard F, Gandon J. Postoperative wound infections: the influence of ultraviolet irradiation of the operating room and of various other factors. Ann Surg 1964;160(Suppl 1):1-192.
5. Horan TC, Gaynes RP, Martone WJ, et al. Definitions of nosocomial surgical site infections; 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol 1992;13:606-8.
6. Mangram AJ, Horan TC, Pearson ML, et al. Guideline for prevention of surgical site infection. Am J Infect Control 1999;27:97-134.
7. Rothenburger S, Spangler D, Bhende S, et al. In vitro antibacterial evaluation of coated Vicryl plus antibacterial (polyglactin 910) suture (coated polyglactin 910 with triclosan) using zone of inhibition assays. Surg Infect Larchmt 2002;3(Suppl 1):S79-87.
8. Barbolt TA. Chemistry and safety of triclosan and its use as an antibacterial coating on coated Vicryl plus antibacterial (polyglactin 910) suture (coated polyglactin 910 with triclosan). Surg Infect Larchmt 2002;3(Suppl 1):S45-54.
9. Storch M, Scalzo H, Jacinto G. Physical and functional comparison of coated Vicryl plus antibacterial (polyglactin 910) suture (coated polyglactin 910 with triclosan) with coated Vicryl (polyglactin 910) suture. Surg Infect Larchmt 2002;3(Suppl 1):S65-77.
10. Storch M, Perry LC, Davidson JM, et al. A 28-day study of the effect of coated Vicryl plus antibacterial suture (coated polyglactin 910 with triclosan) on wound healing in linear incisional skin wounds. Surg Infect Larchmt 2002;3(Suppl 1):S89-98.
11. Ford HR, Jones P, Gaines B, et al. Intra-operative handling and wound healing: controlled clinical trial comparing coated Vicryl plus antibacterial suture (coated polyglactin 910 suture with triclosan) with coated Vicryl suture (polyglactin 910 suture). Surg Infect Larchmt 2005;6:3.
12. Gilbert P, McBain AJ, Storch ML, et al. Literature-based evaluation of the potential risks associated with impregnation of medical devices and implants with triclosan. Surg Infect Larchmt 2002;3(Suppl 1):S55-64.
13. Aiello AE, Marshall B, Levy SB, et al. Relationship between triclosan and susceptibilities of bacteria isolated from hands in the community. Antimicrob Agents Chemother 2004;48:2973-9. (Pubitemid 38989163)
14. Altemeier WA. Sepsis in surgery. Presidential address. Arch Surg 1982;117:107-12. (Pubitemid 12173409)
15. DiPiro JT, Martindale RG, Bakst A, et al. Infection in surgical patients: effects on mortality, hospitalization, and post-discharge care. Am J Health Syst Pharm 1998;55:777-81. (Pubitemid 28193675)
16. Edmiston CE, Seabrook GR, Goheen MP, et al. Bacterial adherence to surgical sutures: can antibacterial-coated sutures reduce the risk of microbial contamination? J Am Coll Surg 2006;203:481-98.
17. Beltra-Pico R, Alonso-Jimenez L, Castro-Sanchez M, et al. Prospective study comparing the incidence of wound infection following appendectomy for acute appendicitis in children: conventional treatment versus reabsorbable antibacterial suture or gentamycin-impregnated collagen sponge. Cir Pediatr 2008;21:199-202.
18. Justinger C, Moussavian MR, Schlueter C, et al. Antibiotic coating of abdominal sutures and wound infection. J Surg 2009;145:330-4.
19. Rozzelle CJ, Leonardo J, Li V. Antimicrobial suture wound closure for cerebrospinal fluid shunt surgery: a prospective, double-blinded, randomized controlled trial. J Neurosurg Pediatr 2008;2:111-7.
20. Fleck T, Moidl R, Blacky A, et al. Triclosan-coated sutures for the reduction of sternal wound infections: economic considerations. Ann Thorac Surg 2007;84:2139.